1. Structural Biology and Molecular Biophysics

Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor

  1. Fenghui Zhao
  2. Chao Zhang
  3. Qingtong Zhou
  4. Kaini Hang
  5. Xinyu Zou
  6. Yan Chen
  7. Fan Wu
  8. Qidi Rao
  9. Antao Dai
  10. Wanchao Yin
  11. Dan-Dan Shen
  12. Yan Zhang
  13. Tian Xia
  14. Raymond C Stevens
  15. Eric Xu  Is a corresponding author
  16. Dehua Yang  Is a corresponding author
  17. Lihua Zhao  Is a corresponding author
  18. Ming-Wei Wang  Is a corresponding author
  1. Fudan University, China
  2. ShanghaiTech University, China
  3. Huazhong University of Science and Technology, China
  4. Shanghai Institute of Materia Medica, China
  5. Zhejiang University School of Medicine, China
https://doi.org/10.7554/eLife.68719
Share this article
Cite this article
  1. Fenghui Zhao
  2. Chao Zhang
  3. Qingtong Zhou
  4. Kaini Hang
  5. Xinyu Zou
  6. Yan Chen
  7. Fan Wu
  8. Qidi Rao
  9. Antao Dai
  10. Wanchao Yin
  11. Dan-Dan Shen
  12. Yan Zhang
  13. Tian Xia
  14. Raymond C Stevens
  15. Eric Xu
  16. Dehua Yang
  17. Lihua Zhao
  18. Ming-Wei Wang
(2021)
Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
eLife 10:e68719.
https://doi.org/10.7554/eLife.68719
  2. Download BibTeX
  3. Download .RIS

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that exerts crucial metabolic functions by binding and activating its cognate receptor, GIPR. As an important therapeutic target, GIPR has been subjected to intensive structural studies without success. Here, we report the cryo-EM structure of the human GIPR in complex with GIP and a Gs heterotrimer at a global resolution of 2.9 Å. GIP adopts a single straight helix with its N terminus dipped into the receptor transmembrane domain (TMD), while the C-terminus is closely associated with the extracellular domain and extracellular loop 1. GIPR employs conserved residues in the lower half of the TMD pocket to recognize the common segments shared by GIP homologous peptides, while uses non-conserved residues in the upper half of the TMD pocket to interact with residues specific for GIP. These results provide a structural framework of hormone recognition and GIPR activation.

Data availability

Atomic coordinates of the GIP-GIPR-Gs complex have been deposited in the Protein Data Bank under accession code 7DTY and Electron Microscopy Data Bank (EMDB) accession code EMD-30860.All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 2, Figure 1-figure supplement 1 and Figure 4-figure supplement 4.

Article and author information

Author details

  1. Fenghui Zhao

    School of Pharmacy, Fudan University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  2. Chao Zhang

    School of Life Science and Technology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Qingtong Zhou

    School of Basic Medical Sciences, Fudan University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  4. Kaini Hang

    School of Life Science and Technology,, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  5. Xinyu Zou

    School of Artificial Intelligence and Automation, Huazhong University of Science and Technology, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.

  6. Yan Chen

    School of Pharmacy, Fudan University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  7. Fan Wu

    School of Life Science and Technology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  8. Qidi Rao

    School of Life Science and Technology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  9. Antao Dai

    The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  10. Wanchao Yin

    The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  11. Dan-Dan Shen

    Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
    Competing interests
    The authors declare that no competing interests exist.

  12. Yan Zhang

    Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
    Competing interests
    The authors declare that no competing interests exist.

  13. Tian Xia

    School of Artificial Intelligence and Automation, Huazhong University of Science and Technology, Wuhan, China
    Competing interests
    The authors declare that no competing interests exist.

  14. Raymond C Stevens

    School of Life Science and Technology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.

  15. Eric Xu

    The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Shanghai, China
    For correspondence
    eric.xu@simm.ac.cn
    Competing interests
    The authors declare that no competing interests exist.

  16. Dehua Yang

    The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Shanghai, China
    For correspondence
    dhyang@simm.ac.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3028-3243

  17. Lihua Zhao

    The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, China, China
    For correspondence
    zhaolihuawendy@simm.ac.cn
    Competing interests
    The authors declare that no competing interests exist.

  18. Ming-Wei Wang

    The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Shanghai, China
    For correspondence
    mwwang@simm.ac.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6550-9017

Funding

National Natural Science Foundation of China (81872915)

  • Ming-Wei Wang

Shanghai Municipal Science and Technology Major Project (2019SHZDZX02)

  • Eric Xu

Strategic Priority Research Program of Chinese Academy of Sciences (XDB37030103)

  • Eric Xu

Shanghai Municipality Science and Technology Development Fund (18430711500)

  • Ming-Wei Wang

Novo Nordisk-CAS Research Fund (NNCAS-2017-1-CC)

  • Dehua Yang

Shanghai Science and Technology Development Foundation (18ZR1447800)

  • Dehua Yang

The Young Innovator Association of CAS (2018325)

  • Lihua Zhao

SA-SIBS Scholarship Program

  • Dehua Yang
  • Lihua Zhao

National Natural Science Foundation of China (32071203)

  • Lihua Zhao

National Natural Science Foundation of China (81773792)

  • Dehua Yang

National Natural Science Foundation of China (81973373)

  • Dehua Yang

National Natural Science Foundation of China (21704064)

  • Qingtong Zhou

National Science and Technology Major Project of China (2018ZX09735-001)

  • Ming-Wei Wang

National Science and Technology Major Project of China (2018ZX09711002-002-005)

  • Dehua Yang

National Key Basic Research Program of China (2018YFA0507000)

  • Ming-Wei Wang

Ministry of Science and Technology of the People's Republic of China (2018YFA0507002)

  • Eric Xu

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Zhao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,279
    views
  • 728
    downloads
  • 36
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fenghui Zhao
  2. Chao Zhang
  3. Qingtong Zhou
  4. Kaini Hang
  5. Xinyu Zou
  6. Yan Chen
  7. Fan Wu
  8. Qidi Rao
  9. Antao Dai
  10. Wanchao Yin
  11. Dan-Dan Shen
  12. Yan Zhang
  13. Tian Xia
  14. Raymond C Stevens
  15. Eric Xu
  16. Dehua Yang
  17. Lihua Zhao
  18. Ming-Wei Wang
(2021)
Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor
eLife 10:e68719.
https://doi.org/10.7554/eLife.68719

Share this article

https://doi.org/10.7554/eLife.68719

Categories and tags

Research organism

Further reading

    1. Structural Biology and Molecular Biophysics

    Flexibility in PAM recognition expands DNA targeting in xCas9

    Kazi A Hossain, Lukasz Nierzwicki ... Giulia Palermo
    Research Article

    xCas9 is an evolved variant of the CRISPR-Cas9 genome editing system, engineered to improve specificity and reduce undesired off-target effects. How xCas9 expands the DNA targeting capability of Cas9 by recognising a series of alternative protospacer adjacent motif (PAM) sequences while ignoring others is unknown. Here, we elucidate the molecular mechanism underlying xCas9’s expanded PAM recognition and provide critical insights for expanding DNA targeting. We demonstrate that while wild-type Cas9 enforces stringent guanine selection through the rigidity of its interacting arginine dyad, xCas9 introduces flexibility in R1335, enabling selective recognition of specific PAM sequences. This increased flexibility confers a pronounced entropic preference, which also improves recognition of the canonical TGG PAM. Furthermore, xCas9 enhances DNA binding to alternative PAM sequences during the early evolution cycles, while favouring binding to the canonical PAM in the final evolution cycle. This dual functionality highlights how xCas9 broadens PAM recognition and underscores the importance of fine-tuning the flexibility of the PAM-interacting cleft as a key strategy for expanding the DNA targeting potential of CRISPR-Cas systems. These findings deepen our understanding of DNA recognition in xCas9 and may apply to other CRISPR-Cas systems with similar PAM recognition requirements.

    1. Structural Biology and Molecular Biophysics

    Molecular determinants of Neu5Ac binding to a tripartite ATP independent periplasmic (TRAP) transporter

    Parveen Goyal, KanagaVijayan Dhanabalan ... Subramanian Ramaswamy
    Research Advance

    N -Acetylneuraminic acid (Neu5Ac) is a negatively charged nine-carbon amino sugar that is often the peripheral sugar in human cell-surface glycoconjugates. Some bacteria scavenge, import, and metabolize Neu5Ac or redeploy it on their cell surfaces for immune evasion. The import of Neu5Ac by many bacteria is mediated by tripartite ATP-independent periplasmic (TRAP) transporters. We have previously reported the structures of SiaQM, a membrane-embedded component of the Haemophilus influenzae TRAP transport system, (Currie et al., 2024). However, none of the published structures contain Neu5Ac bound to SiaQM. This information is critical for defining the transport mechanism and for further structure-activity relationship studies. Here, we report the structures of Fusobacterium nucleatum SiaQM with and without Neu5Ac. Both structures are in an inward (cytoplasmic side) facing conformation. The Neu5Ac-bound structure reveals the interactions of Neu5Ac with the transporter and its relationship with the Na+ binding sites. Two of the Na+-binding sites are similar to those described previously. We identify a third metal-binding site that is further away and buried in the elevator domain. Ser300 and Ser345 interact with the C1-carboxylate group of Neu5Ac. Proteoliposome-based transport assays showed that Ser300-Neu5Ac interaction is critical for transport, whereas Ser345 is dispensable. Neu5Ac primarily interacts with residues in the elevator domain of the protein, thereby supporting the elevator with an operator mechanism. The residues interacting with Neu5Ac are conserved, providing fundamental information required to design inhibitors against this class of proteins.

    1. Computational and Systems Biology
    2. Structural Biology and Molecular Biophysics

    Discovery of a heparan sulfate binding domain in monkeypox virus H3 as an anti-poxviral drug target combining AI and MD simulations

    Bin Zheng, Meimei Duan ... Peng Zheng
    Research Article

    Viral adhesion to host cells is a critical step in infection for many viruses, including monkeypox virus (MPXV). In MPXV, the H3 protein mediates viral adhesion through its interaction with heparan sulfate (HS), yet the structural details of this interaction have remained elusive. Using AI-based structural prediction tools and molecular dynamics (MD) simulations, we identified a novel, positively charged α-helical domain in H3 that is essential for HS binding. This conserved domain, found across orthopoxviruses, was experimentally validated and shown to be critical for viral adhesion, making it an ideal target for antiviral drug development. Targeting this domain, we designed a protein inhibitor, which disrupted the H3-HS interaction, inhibited viral infection in vitro and viral replication in vivo, offering a promising antiviral candidate. Our findings reveal a novel therapeutic target of MPXV, demonstrating the potential of combination of AI-driven methods and MD simulations to accelerate antiviral drug discovery.